Following a change in the recommendation for booster doses of meningococcal B and ACWY vaccines for those at increased risk of invasive meningococcal disease, MVEC have updated their guidance on the immunisation of people with asplenia or hyposplenia.
The spleen plays an important role in preventing infection by removing bacteria (particularly encapsulated bacteria) from the blood stream. Individuals with anatomical asplenia or hyposplenia are therefore at an increased risk of infection. In addition to being up to date with National Immunisation Program (NIP) and COVID-19 vaccines, individuals with asplenia or hyposplenia are recommended and funded to receive extra vaccines.
To view these recommendations please refer to MVEC: Asplenia and hyposplenia